Rakuten Medical, Inc.

Biotech San Diego, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
San Diego, CA
Street
6885 Flanders Drive, Suite 100
Zip
92121

Offering

Total offering
$116.7M
Amount sold
$111.5M
First sale
Jul 11, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
26

How this filing compares

Ranked #1 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 38.9× the median.

Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP

Leadership

Maeda Minami — Executive Officer

David Chao — Director

Mazen Darwazah — Director

Miguel Garcia-Guzman — Director

Kentaro Hyakuno — Director

Hiroshi Mikitani — Executive Officer (also: Director)

Hiroshi Mori — Director

Nitin Nohria — Director

Eiichi Kaga — Director

Tiffany Piecewicz — Executive Officer

Abhijit Bhatia — Executive Officer

Carlos Garcia — Executive Officer

Toshiaki Suzuki — Executive Officer

Hiroyuki Kodama — Executive Officer

Suzane San — Executive Officer

Filing details

Rakuten Medical, Inc. filed a Form D with the SEC on April 13, 2026.

Other newest Biotech companies

Other newest companies in California